Showing results (201-210 of 267) with videos related to
Sort By:
Pageof 27
Psychiatry Research|December 20, 1996
Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorderM C O'Donnell, S V Catts, P B Ward, et al.British Journal of Rheumatology|August 26, 1998
Chemokine expression and leucocyte infiltration in Sjögren's syndromeC Cuello, P Palladinetti, N Tedla, et al.Pediatric Blood & Cancer|October 6, 2005
How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia?Nancy L Young, Catharine S Bradley, Cindy D Wakefield, et al.Scandinavian Journal of Gastroenterology|November 1, 1996
Luminal immunity in small-intestinal bacterial overgrowth and old ageS M Riordan, C J McIver, D Wakefield, et al.The American Journal of Gastroenterology|March 10, 2001
Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut floraS M Riordan, C J McIver, D Wakefield, et al.British Journal of Haematology|December 21, 2002
Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpuraManuel D Carcao, Victor S Blanchette, Cindy D Wakefield, et al.Bioorganic & Medicinal Chemistry Letters|February 4, 2011
Scaffold oriented synthesis. Part 4: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactionsIrini Akritopoulou-Zanze, Brian D Wakefield, Alan Gasiecki, et al.Bioorganic & Medicinal Chemistry Letters|February 2, 2011
Scaffold oriented synthesis. Part 3: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing [2+3] cycloadditionsIrini Akritopoulou-Zanze, Brian D Wakefield, Alan Gasiecki, et al.Annals of the Rheumatic Diseases|February 1, 1989
Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosusJ A Charlesworth, P W Peake, J Golding, et al.British Journal of Cancer|February 22, 2007
The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancerA Hettiaratchi, N J Hawkins, G McKenzie, et al.Pageof 27